secwatch.observer — SEC 8-K summary
======================================

Issuer:     POINT Biopharma Global Inc. (—)
CIK:        0001811764
Form:       8-K
Filed at:   2023-08-03T23:59:59+00:00
Accession:  0001811764-23-000031
Event type: other
Sentiment:  neutral
Materiality: 0.40
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

POINT Biopharma Global auditor Armanino resigns; Deloitte & Touche appointed as new independent auditor
--------------------------------------------------------------------------------

- Armanino resigned as auditor effective upon filing of Q2 2023 10-Q due to its decision to cease public company audit services.
- No disagreements or reportable events between the Company and Armanino during the past two fiscal years or subsequent interim period.
- Audit Committee and Board approved engagement of Deloitte & Touche as independent auditor for fiscal year ending December 31, 2023.
- No prior consultations with Deloitte on accounting principles, transactions, or audit opinions during the prior two years.
- Armanino filed a letter with the SEC agreeing with the Company's statements regarding the resignation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811764/000181176423000031/0001811764-23-000031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811764/000181176423000031/pnt-20230728.htm
  HTML page:      https://secwatch.observer/filing/0001811764-23-000031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer